About

Affect Therapeutics offers a digital platform for addiction recovery that combines financial incentives, therapy, and medication through a method called "contingency management." This approach rewards positive behaviors to help individuals form healthier habits and is conducted via secure video conferences, ensuring convenience and privacy. The company also addresses other life challenges that can impact recovery, such as job searching and financial management, providing a holistic support system. The goal is to help individuals achieve sobriety while improving their overall quality of life.

Simplify's Take

What believers are saying

• The recent $16M Series A funding will enable Affect to expand nationally, enhancing its reach and impact.
• Affect's science-based approach, backed by NIH-sponsored studies, ensures that the treatment methods are effective and credible.
• The company's digital platform allows for continuous innovation and improvement, potentially leading to better recovery outcomes and user experience.

What critics are saying

• The digital healthcare space is highly competitive, and Affect must continuously innovate to stay ahead.
• Reliance on a subscription or fee-for-service model may limit accessibility for lower-income individuals who need treatment.

What makes Affect Therapeutics unique

• Affect Therapeutics leverages a unique combination of financial incentives, therapy, and medication, setting it apart from traditional addiction recovery programs.
• The company's fully digital platform offers unparalleled convenience and privacy, making it accessible to individuals who may avoid traditional rehab settings.
• Affect's holistic approach, addressing not just addiction but also life circumstances like job hunting and bill management, provides a comprehensive support system for recovery.